Status epilepticus

Common Name(s)

Status epilepticus

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Status epilepticus" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Status epilepticus" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Status epilepticus" returned 673 free, full-text research articles on human participants. First 3 results:

Silencing Status Epilepticus-Induced BDNF Expression with Herpes Simplex Virus Type-1 Based Amplicon Vectors.
 

Author(s): Chiara Falcicchia, Pascal Trempat, Anna Binaschi, Coline Perrier-Biollay, Paolo Roncon, Marie Soukupova, Hervé Berthommé, Michele Simonato

Journal:

 

Brain-derived neurotrophic factor (BDNF) has been found to produce pro- but also anti-epileptic effects. Thus, its validity as a therapeutic target must be verified using advanced tools designed to block or to enhance its signal. The aim of this study was to develop tools to silence ...

Last Updated: 9 Mar 2016

Go To URL
Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score.
 

Author(s): Qiong Gao, Tang-peng Ou-Yang, Xiao-long Sun, Feng Yang, Chen Wu, Tao Kang, Xiao-gang Kang, Wen Jiang

Journal:

 

Prediction of the functional outcome for patients with convulsive status epilepticus (CSE) has been a challenge. The aim of this study was to characterize the prognostic factors and functional outcomes of patients after CSE in order to develop a practicable scoring system for outcome prediction.

Last Updated: 26 Feb 2016

Go To URL
A Low Mortality, High Morbidity Reduced Intensity Status Epilepticus (RISE) Model of Epilepsy and Epileptogenesis in the Rat.
 

Author(s): Tamara Modebadze, Nicola H Morgan, Isabelle A A Pérès, Rebecca D Hadid, Naoki Amada, Charlotte Hill, Claire Williams, Ian M Stanford, Christopher M Morris, Roland S G Jones, Benjamin J Whalley, Gavin L Woodhall

Journal:

 

Animal models of acquired epilepsies aim to provide researchers with tools for use in understanding the processes underlying the acquisition, development and establishment of the disorder. Typically, following a systemic or local insult, vulnerable brain regions undergo a process ...

Last Updated: 25 Feb 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Status epilepticus" returned 126 free, full-text review articles on human participants. First 3 results:

Lidocaine for status epilepticus in adults.
 

Author(s): F A Zeiler, K J Zeiler, C J Kazina, J Teitelbaum, L M Gillman, M West

Journal: Seizure. 2015 Sep;31():41-8.

 

Our goal was to perform a systematic review of the literature on the use of intravenous lidocaine in adults for status epilepticus (SE) and refractory status epilepticus (RSE) to determine its impact on seizure control.

Last Updated: 12 Sep 2015

Go To URL
Pharmacotherapy for Status Epilepticus.
 

Author(s): Eugen Trinka, Julia Höfler, Markus Leitinger, Francesco Brigo

Journal: Drugs. 2015 Sep;75(13):1499-521.

 

Status epilepticus (SE) represents the most severe form of epilepsy. It is one of the most common neurologic emergencies, with an incidence of up to 61 per 100,000 per year and an estimated mortality of 20 %. Clinically, tonic-clonic convulsive SE is divided into four subsequent stages: ...

Last Updated: 4 Sep 2015

Go To URL
Ketamine for the treatment of refractory status epilepticus.
 

Author(s): Yao Fang, Xuefeng Wang

Journal: Seizure. 2015 Aug;30():14-20.

 

Status epilepticus (SE) is an acute and severe illness of the central nervous system, and prolonged SE can lead to brain damage and even death. Ketamine is a noncompetitive antagonist of glutamatergic N-methyl-d-aspartate (NMDA) receptors. During prolonged seizures, the numbers and ...

Last Updated: 28 Jul 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Ketogenic Diet for Refractory Status Epilepticus
 

Status: Recruiting

Condition Summary: Status Epilepticus; Seizure; Epilepsy; Refractory Status Epilepticus; Medically Resistant Status Epilepticus

 

Last Updated: 31 Aug 2016

Go to URL
Ketamine in Refractory Convulsive Status Epilepticus
 

Status: Recruiting

Condition Summary: Status Epilepticus

 

Last Updated: 4 May 2015

Go to URL
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan
 

Status: Recruiting

Condition Summary: Status Epilepticus

 

Last Updated: 12 Aug 2016

Go to URL